info@australianvisionresearch.org

DONATE NOW

Australian Vision Research
  • About
    • About
    • Contact
    • News
  • Grants
  • Excellence Awards
  • Research
  • AVR Insights
  • Members
  • AVR Bequest Program
  • Donate
Perth Eye Foundation Grant: RNA base editing for treatment of inherited retinal diseases

Perth Eye Foundation Grant: RNA base editing for treatment of inherited retinal diseases

by AVR Supporters | Jun 10, 2025 | Research

AVR Funded Grant – 2022   Project Title: RNA base editing for treatment of inherited retinal diseases Chief Investigator: A/Prof Liu Guei-Sheung Co-Investigators: Dr Livia Carvalho, Prof Bang V. Bui, Dr Lewis Fry, Dr David Cordeiro Sousa Aim This project aims to...
Identifying cardiovascular disease parameters with high clinical relevance in primary open-angle glaucoma

Identifying cardiovascular disease parameters with high clinical relevance in primary open-angle glaucoma

by AVR Supporters | Apr 8, 2025 | Research

Chief Investigator: Dr Ayub QassimCo-investigators: Dr Henry Marshall, Dr John Landers AimTo identify individual plasma lipid species, as well as ambulatory and nocturnal blood pressure markers relevant to POAG progression. MethodsThe relationship between 854 lipid...
Amyloid and Tau targeting to protect Retinal Ganglion Cell and Optic Nerve in glaucoma

Amyloid and Tau targeting to protect Retinal Ganglion Cell and Optic Nerve in glaucoma

by AVR Supporters | Mar 12, 2025 | Research

Chief Investigator: A/Prof Vivek GuptaCo-investigators: Prof Stuart Graham, A/Prof Mehdi Mirzaei AimThe aim of this study was to determine whether amyloid accumulation and Tauhyperphosphorylation are causes of neurodegenerative pathology in glaucoma. Weaimed to...
Targeting Nrf2-MAFF pathway in Müller cells to treat macular degeneration

Targeting Nrf2-MAFF pathway in Müller cells to treat macular degeneration

by AVR Supporters | Feb 11, 2025 | Research

Chief Investigator: Dr Ling ZhuCo-investigators: Prof Mark Gillies, Dr Ting Zhang AimThis project was about understanding how a specific protein, MAFF, helps retina cope with harmful conditions and whether boosting this protein could prevent macular degeneration....
The Bacterial Ocular Surveillance System (BOSS)

The Bacterial Ocular Surveillance System (BOSS)

by AVR Supporters | Oct 31, 2024 | Research

AVR Funded Grant – 2022   Project Title: The Bacterial Ocular Surveillance System (BOSS)   Chief Investigator: Professor Stephanie Watson   Co-Investigators: Prof Monica Lahra, A/Prof Richard Mills, Dr Steve Wiffen, Dr Maria Cabrera- Aguas   Aim...
Hyperspectral retinal imaging perfusion maps for retinal vascular diseases

Hyperspectral retinal imaging perfusion maps for retinal vascular diseases

by AVR Supporters | Aug 18, 2024 | Research

AVR Funded Grant – 2022 Project Title: Hyperspectral retinal imaging perfusion maps for retinal vascular diseases   Chief Investigator: A/Professor Peter van Wijingarde   Co-Investigators: Dr Xavier Hadoux, A/Prof Lyndell Lim, Dr Amy Cohn, Darvy Dang...
« Older Entries

Recent Posts

  • Perth Eye Foundation Grant: RNA base editing for treatment of inherited retinal diseases
  • Identifying cardiovascular disease parameters with high clinical relevance in primary open-angle glaucoma
  • Grants Round 2025 Open
  • Amyloid and Tau targeting to protect Retinal Ganglion Cell and Optic Nerve in glaucoma
  • Targeting Nrf2-MAFF pathway in Müller cells to treat macular degeneration

Recent Comments

No comments to show.
Australian Vision Research

© Copyright 2024 Australian Vision Research ABN 37008393146

About
Grants
Research
News
Members
Contact

CONTACT US

PO BOX 3109
Erina NSW 2250
 

For all enquiries contact us on

info@australianvisionresearch.org

Privacy Policy

  • Follow
  • Follow
  • Follow
  • Follow

Australian Vision Research conforms to the highest corporate governance standards with its fully audited annual financial statements and reports publicly available.